Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive disease that is prevalent among eastern Mediterranean populations, mainly non-Ashkenazi Jews, Armenians, Turks, and Arabs. Since a large proportion of all the FMF patients in the world live in Turkey, the Turkish FMF Study Group (FMF-TR) was founded to develop a patient registry database and analyze demographic, clinical, and genetic features. The cohort was composed of 2838 patients (mean age, 23.0 +/- 13.33 yr; range, 2-87 yr), with a male:female ratio of 1.2:1. There was a mean period of 6.9 +/- 7.65 years from disease onset to diagnosis; the period was about 2 years shorter for each decade since 1981. Ninety-four percent of patients were living in the central-western parts of the country; however, their familial origins (70% from the central-eastern and Black Sea regions) reflected not only the ongoing east to west migration, but also the historical roots of FMF in Turkey. Patients' clinical features included peritonitis (93.7%), fever (92.5%), arthritis (47.4%), pleuritis (31.2%), myalgia (39.6%), and erysipelas-like erythema (20.9%). Arthritis, arthralgia, myalgia, and erysipelas-like erythema were significantly more frequent (p < 0.001) among patients with disease onset before the age of 18 years. Genetic analysis of 1090 patients revealed that M694V was the most frequent mutation (51.4%), followed by M680I (14.4%) and V726A (8.6%). Patients with the M694V/M694V genotype were found to have an earlier age of onset and higher frequencies of arthritis and arthralgia compared with the other groups (both p < 0.001). In contrast to other reported studies, there was no correlation between amyloidosis and M694V homozygosity in this cohort. However, amyloidosis was still remarkably frequent in our patients (12.9%), and it was prevalent (27.8%) even among the 18 patients with a disease onset after age 40 years. Twenty-two patients (0.8%) had nonamyloid glomerular diseases. The high prevalence of vasculitides (0.9% for polyarteritis nodosa and 2.7% for Henoch-Schonlein purpura) and high frequency of pericarditis (1.4%) were striking findings in the cohort. Phenotype II cases (those patients with amyloidosis as the presenting or only manifestation of disease) were rare (0.3% or less). There was a high rate of a past diagnosis of acute rheumatic fever, which suggested a possible misdiagnosis in children with FMF presenting with recurrent arthritis. To our knowledge, this is the largest series of patients with FMF reported from 1 country. We describe the features of the disease in the Turkish population and show that amyloidosis is still a substantial problem.

References

    1. Akar N, Misirlioglu M, Yalcinkaya F, Akar E, Cakar N, Tumer N, Akcakus M, Tastan H, Matzner Y. MEFV mutations in Turkish patients suffering from familial mediterranean fever. Hum Mutat. 2000;15:118-119.
    1. Akar N, Hasipek M, Akar E, Ekim M, Yalcinkaya F, Cakar N. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid. 2003;10:12-16.
    1. Ben-Chetrit E, Backenroth R. Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum Dis. 2001;60:146-149.
    1. Ben-Chetrit E, Urieli-Shoval S, Calko S, Abeliovich D, Matzner Y. Molecular diagnosis of FMF: lessons from a study of 446 unrelated individuals. Clin Exp Rheumatol. 2002;20(Suppl 26):S25-S29.
    1. Ben-Chetrit E, Yazici H. Thoughts on the proposed links between Behcet's disease and familial Mediterranean fever. Clin Exp Rheumatol. 2002;20(Suppl 26):S1-S2.
    1. Benhamou E, Albou A, Destaing F, Ferrand B, Boineau N. Periarterite noueseuse et malade periodique. Bull Soc Med Hop Paris. 1954;70:247-254.
    1. Booth DR, Bennetts B, Christodoulou J, Steward G. FMF in Australia-an under-diagnosed disease [abstract]. Clin Exp Rheumatol. 2002;20(Suppl 26):S-90.
    1. Booth DR, Gillmore JD, Booth SE, Pepys MB, Hawkins PN. Pyrin/Maronestrin mutations in familial Mediterranean fever. QJM. 1998;91:603-606.
    1. Booth DR, Lachmann HJ, Gillmore JD, Booth SE, Hawkins PN. Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. QJM. 2001;94:527-531.
    1. Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics. 1999;103:e70.
    1. Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet. 2000;67:1136-1143.
    1. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dode C, Grateau G, Amselem S. MEFV-Gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet. 1999;65:88-97.
    1. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, Kastner DL. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591-604.
    1. Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A, Dross C, Dupont M, Notarnicola C, Levy M, Rosner I, Demaille J, Touitou I. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet. 1998;6:95-97.
    1. Dinc A, Pay S, Turan M, Simsek I. Prevalence of familial Mediterranean fever in young Turkish men [abstract]. Clin Exp Rheumatol. 2000;18:292.
    1. Eliakim M, Ehrenfeld EN. Electrocardiographic changes in recurrent polyserositis ("periodic disease"). Am J Cardiol. 1961;7:517-520.
    1. Erol C, Sonel A, Candan I, Omurlu K, Akyol T. Pericardial involvement in familial Mediterranean fever. Postgrad Med J. 1988;64:453-454.
    1. Flatau E, Kohn D, Schiller D, Lurie M, Levy E. Schonlein-Henoch syndrome in patients with familial Mediterranean fever. Arthritis Rheum. 1982;25:42-47.
    1. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nature Genet. 1997;17:25-31.
    1. Gale A, Levin ME. Pericarditis and auricular fibrillation. Occurrence in familial Mediterranean fever. Arch Intern Med. 1963;112:234-241.
    1. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum. 2003;48:1149-1155.
    1. Gershoni-Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schoenlein purpura. J Pediatr. 2003;143:658-661.
    1. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med. 1972;287:1302.
    1. International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797-807.
    1. Janeway TC, Mosenthal HO. Unusual paroxysmal syndrome, probably allied to recurrent vomiting, with a study of nitrogen metabolism. Trans Assoc Am Physicians. 1908;23:504-518.
    1. Kastner DL, O'Shea JJ. A fever gene comes in from the cold. Nature Genet. 2001;29:241-242.
    1. Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). QJM. 1997;90:643-647.
    1. Kogan A, Shinar Y, Lidar M, Revivo A, Langevitz P, Padeh S, Pras M, Livneh A. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet. 2001;102:272-276.
    1. Kone Paut I, Dubuc M, Sportouch J, Minodier P, Garnier JM, Touitou I. Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology (Oxford). 2000;39:1275-1279.
    1. Konstantopoulos K, Kanta A, Tzoulianos M, Dimou S, Sotsiou F, Politou M, Loukopoulos D. Familial Mediterranean fever phenotype II in Greece. Isr Med Assoc J. 2001;3:862-863.
    1. Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 2002;6:79-81.
    1. Korner H, Soreide JA, Pedersen EJ, Bru T, Sondenaa K, Vatten L. Stability in incidence of acute appendicitis. A population-based longitudinal study. Dig Surg. 2001;18:61-66.
    1. Kutlay S, Yilmaz E, Koytak ES, Tulunay OO, Keven K, Ozcan M, Erturk S. A case of familial Mediterranean fever with amyloidosis as the first manifestation. Am J Kidney Dis. 2001;38:E34.
    1. Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, Pras E. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid. 1999;6:1-6.
    1. Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol. 2000;14:477-498.
    1. Majeed HA, El-Shanti H, Al-Khateeb MS, Rabaiha ZA. Genotype/phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum. 2002;31:371-376.
    1. Mamou H, Cattan R. La maladie periodique (sur 14 cas personnels dont 8 compliques de nephropathies). Sem Hop Paris. 1952;28:1062-1070.
    1. Mansour I, Delague V, Cazeneuve C, Dode C, Chouery E, Pecheux C, Medlej-Hashim M, Salem N, El Zein L, Levan-Petit I, Lefranc G, Goossens M, Delpech M, Amselem S, Loiselet J, Grateau G, Megarbane A, Naman R. Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. Eur J Hum Genet. 2001;9:51-55.
    1. Marmarali A. Garip bir karin sendromu. Turk Tip Cemy Mecm. 1946;12:436-443.
    1. Masatlioglu S, Dulundu E, Hatemi G, Ozdogan H. The frequency of familial Mediterranean fever in an emergency setting [abstract]. Clin Exp Rheumatol. 2002;20(Suppl 26):S-92.
    1. Masumoto J, Dowds TA, Schaner P, Chen FF, Ogura Y, Li M, Zhu L, Katsuyama T, Sagara J, Taniguchi S, Gumucio DL, Nunez G, Inohara N. ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun. 2003;303:69-73.
    1. Melikoglu M, Ozdogan H, Korkmaz C, Kasapcopur O, Arisoy N, Akkus S, Fresko Z, Yazici H. A survey of phenotype II in familial Mediterranean fever. Ann Rheum Dis. 2000;59:910-913.
    1. Michet CJ. Epidemiology of vasculitis. Rheum Dis Clin North Am. 1990;16:261-268.
    1. Mimouni A, Magal N, Stoffman N, Shohat T, Minasian A, Krasnov M, Halpern GJ, Rotter JI, Fischel-Ghodsian N, Danon YL, Shohat M. Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics. 2000;105:E70.
    1. Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I. Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun. 2002;3:43-45.
    1. Ohmann C, Franke C, Kraemer M, Yang Q. Neues zur Epidemiologie der akuten Appendizitis. Chirurg. 2002;73:769-776.
    1. Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H. Increased frequency of familial Mediterranean fever in Central Anatolia, in Turkey. Clin Exp Rheumatol. 2004;4(Suppl 34):S31-33.
    1. Ozdogan H, Arisoy N, Kasapcopur O, Sever L, Caliskan S, Tuzuner N, Mat C, Yazici H. Vasculitis in familial Mediterranean fever. J Rheumatol. 1997;24:323-327.
    1. Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Tinaztepe K, Calguneri M, Turgan C, Turkmen A, Akpolat I, Anaci M, Besbas N, Akpolat T. Polyarteritis nodosa in patients with familial Mediterranean fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum. 2001;30:281-287.
    1. Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E, Tezcan S. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol. 1998;25:2445-2449.
    1. Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Ped. 2003;162:449-454.
    1. Ozkan E, Okur O, Ekmekci A, Ozcan R, Tag T. A new approach to the treatment of periodic fever. Med Bull Istanbul. 1972;5:44-49.
    1. Pras M, Bronshpigel N, Zemer D, Gafni J. Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med J. 1982;150:22-26.
    1. Pras M, Sohar E. Familial Mediterranean fever. In: Klippel JH, Dieppe PA, eds. Rheumatology. St. Louis: Mosby; 1994;30:3-4.
    1. Pras M. FMF: Past, present and future. Clin Exp Rheumatol. 2002;20(Suppl 26):S-66.
    1. Raviv U, Rubinstein A, Schonfeld AE. Pericarditis in familial Mediterranean fever. Am J Dis Child. 1968;116:442-444.
    1. Rawashdeh MO, Majeed HA. Familial Mediterranean fever in Arab children: the high prevalence and gene frequency. Eur J Pediatr. 1996;155:540-544.
    1. Richards N, Schaner P, Diaz A, Stuckey J, Shelden E, Wadhwa A, Gumucio DL. Interaction between pyrin and the apoptotic spec protein (ASC) modulates ASC-induced apoptosis. J Biol Chem. 2001;276:39320-39329.
    1. Rozenbaum M, Rosner I. The clinical features of familial Mediterranean fever of elderly onset. Clin Exp Rheumatol. 1994;12:347-348.
    1. Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr. 1997;156:619-623.
    1. Said R, Hamzeh Y, Said S, Tarawneh M, al-Khateeb M. Spectrum of renal involvement in familial Mediterranean fever. Kidney Int. 1992;41:414-419.
    1. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, Kastner DL. Familial Mediterranean fever at the millenium. Clinical spectrum, ancient mutations and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore). 1998;77:268-297.
    1. Sayhan N, Ozdogan H, Kasapcopur O, Melikoglu M, Altiparmak MR, Tunc R, Yazici H, Sonmez M, Tuzuner N, Erek E, Arisoy N. MEFV gene analysis in familial Mediterranean fever patients from Turkey: prognostic value of M694V homozygous phenotype [abstract]. Clin Exp Rheumatol. 2000;18:286.
    1. Schwabe AD, Peters RS. Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine (Baltimore). 1974;53:453-462.
    1. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behcet's disease in familial Mediterranean fever: Characterization of the association between the two diseases. Semin Arthritis Rheum. 2000;29:286-295.
    1. Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A, Danon Y, Lotan R, Ogur G, Sirin A, Schlezinger M, Halpern GJ, Schwabe A, Kastner D, Rotter JI, Fischel-Ghodsian N. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet. 1999;7:287-292.
    1. Siegal S. Benign paroxysmal peritonitis. Ann Intern Med. 1945;23:1-21.
    1. Siegal S. Familial paroxysmal polyserositis. Analysis of fifty cases. Am J Med. 1964;36:893-918.
    1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227-253.
    1. Tamir N, Langevitz P, Zemer D, Pras E, Shinar Y, Padeh S, Zaks N, Pras M, Livneh A. Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics. Am J Med Genet. 1999;87:30-35.
    1. Tauber T, Zimand S, Kotzer E. Recurrent pericarditis in familial Mediterranean fever. Harefuah. 1995;128:611-612.
    1. Tekin M, Yalcinkaya F, Tumer N, Cakar N, Kocak H, Ozkaya N, Gencgonul H. Familial Mediterranean fever-renal involvement by diseases other than amyloid. Nephrol Dial Transplant. 1999;14:475-479.
    1. Tekin M, Yalcinkaya F, Tumer N, Akar N, Misirlioglu M, Cakar N. Clinical, laboratory and molecular characteristics of children with familial Mediterranean fever associated vasculitis. Acta Pediatr. 2000;89:177-182.
    1. Tekin M, Yalcinkaya F, Cakar N, Akar N, Misirlioglu M, Tastan H, Tumer N. MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? Clin Genet. 2000;57:430-434.
    1. Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P, Seri M, Ozen S, Bakkaloglu A, Karaduman A, Garnier JM, Demaille J, Kone-Paut I. MEFV mutations in Behcet's disease. Hum Mutat. 2000;16:271-272.
    1. Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J, Kone-Paut I. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum. 2001;44:163-169.
    1. Tunca M, Akar S, Booth DR, Booth SE, Bybee A, Soyturk M, Tankurt E, Hawkins PN. Familial Mediterranean fever in western Turkey: Five-year experience in one institution [abstract]. Clin Exp Rheumatol. 2000;18:288.
    1. Tunca M, Akar S, Hawkins PN, Booth SE, Sengul B, Yavuzsen TU, Oktem S, Soyturk M, Akkoc N, Booth DR. The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. Eur J Hum Genet. 2002;10:786-789.
    1. Tunca M, Kirkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN. Acute phase response and evolution of familial Mediterranean fever. Lancet. 1999;353:1415.
    1. Tuncbilek E. Genetic services in Turkey. Eur J Hum Genet. 1997;5(Suppl 2):178-182.
    1. Tutar HE, Imamoglu A, Kendirli T, Akar E, Atalay S, Akar N. Isolated recurrent pericarditis in a patient with familial Mediterranean fever. Eur J Pediatr. 2001;160:264-265.
    1. Tutar E, Akar N, Atalay S, Yilmaz E, Akar E, Yalcinkaya F. Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease. Heart. 2002;87:568-569.
    1. Williams NM, Jackson D, Everson NW, Johnstone JM. Is the incidence of acute appendicitis really falling? Ann R Coll Surg Engl. 1998;80:122-124.
    1. Yalcinkaya F, Akar N, Misirlioglu M. Familial Mediterranean fever-amyloidosis and the Val726Ala mutation. N Engl J Med. 1998;338:993-994.
    1. Yalcinkaya F, Tumer N. Glomerular lesions other than amyloidosis in patients with familial Mediterranean fever. Nephrol Dial Transplant. 1999;14:21-23.
    1. Yalcinkaya F, Cakar N, Misirlioglu M, Tumer N, Akar N, Tekin M, Tastan H, Kocak H, Ozkaya N, Elhan AH. Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology (Oxford). 2000;39:67-72.
    1. Yalcinkaya F, Tekin M, Cakar N, Akar E, Akar N, Tumer N. Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients. QJM. 2000;93:681-684.
    1. Yilmaz E, Balci B, Kutlay S, Ozen S, Erturk S, Oner A, Besbas N, Bakkaloglu A. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk J Pediatr. 2003;45:198-202.
    1. Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, Saatci U, Bakkaloglu A, Ozguc M. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet. 2001;9:553-555.
    1. Yurdakul S, Gunaydin I, Tuzun Y, Tankurt N, Pazarli H, Ozyazgan Y, Yazici H. The prevalence of Behcet's syndrome in a rural area in northern Turkey. J Rheumatol. 1988;15:820-822.
    1. Zemer D, Cabili S, Revach M, Shahin N. Constrictive pericarditis in familial Mediterranean fever. Isr J Med Sci. 1977;13:55-58.
    1. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med. 1974;291:932-934.
    1. Zimand S, Tauber T, Hegesch T, Aladjem M. Familial Mediterranean fever presenting with massive cardiac tamponade. Clin Exp Rheumatol. 1994;12:67-69.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa